Protein Engineering of Luciferase to Enhance Bioluminescent Properties by Schwab, Charles & Wittig, Peter
Santa Clara University
Scholar Commons
Bioengineering Senior Theses Student Scholarship
6-4-2014
Protein Engineering of Luciferase to Enhance
Bioluminescent Properties
Charles Schwab
Santa Clara Univeristy
Peter Wittig
Santa Clara Univeristy
Follow this and additional works at: http://scholarcommons.scu.edu/bioe_senior
Part of the Biomedical Engineering and Bioengineering Commons
This Thesis is brought to you for free and open access by the Student Scholarship at Scholar Commons. It has been accepted for inclusion in
Bioengineering Senior Theses by an authorized administrator of Scholar Commons. For more information, please contact rscroggin@scu.edu.
Recommended Citation
Schwab, Charles and Wittig, Peter, "Protein Engineering of Luciferase to Enhance Bioluminescent Properties" (2014). Bioengineering
Senior Theses. Paper 19.
  
 
 
 
 
 
  BIOE 
 
2 
 
 
Protein Engineering of Luciferase to Enhance Bioluminescent 
Properties 
 
 
by 
 
 
 
Charles Schwab and Peter Wittig 
 
 
 
 
SENIOR DESIGN PROJECT REPORT 
 
 
 
 
 
 
Submitted in partial fulfillment of the requirements 
for the degree of  
Bachelor of Science in Bioengineering  
School of Engineering 
Santa Clara University 
 
 
 
 
 
 
 
 
Santa Clara, California  
 
June 4, 2014 
 
 
 
 
  BIOE 
 
3 
 
Table of Contents 
 
Introduction & Significance  3-12 
 Abstract                                                                                                          4 
 Acknowledgments                                                                                          5 
 Introduction                                                                                                    5-15 
  
                                                                                            
Subsystem Chapters                                                                                                13-30 
 Plasmid Design                                                                                              16-25 
 Mutagenesis                                                                                                   26-29 
 Screening                                                                                                       30-32 
 
Materials and Methods                                                                                            32-35 
 
Results                                                                                                                        35-39 
 
Discussion                                                                                                                  40-41 
 
Conclusion                                                                                                                 41-43 
 
Bibliography                                                                                                              44-45 
 
Appendix                                                                                                                    46 
 
 
 
 
  BIOE 
 
4 
 
Abstract 
Bioluminescence is the ability of naturally occurring organisms to emit light. Many 
instances of bioluminescence have been identified ranging from fireflies to bacteria. The 
protein responsible for bioluminescence in all of these organisms is luciferase. The exact 
function and structure of this protein are still unknown to this day. This project aims at 
better understanding luciferase as well as enhancing its bioluminescent properties. In 
order to work with luciferase, we had to isolate all of the genes necessary for 
bioluminescence. The six genes necessary for bioluminescence are Lux A,B,C,D,E,G. 
We isolated each of these genes from original bacterial DNA. We then put these genes 
back together into our own synthesized plasmids through a method called Gibson 
Assembly. These plasmids were then mutated through a process called site-directed 
mutagenesis. The mutated plasmids were introduced to E.coli cells and mutated protein 
were produced and screened for enhanced bioluminescent properties.  
We were able to successfully isolate all of the DNA fragments necessary for 
bioluminescence. We were then able to successfully create one of the two plasmids 
necessary for bioluminescence. The successful creation of this plasmid shows that we 
were able to successfully isolate and combine the DNA fragments. By shifting a few 
small experimental parameters we should be able to complete our second plasmid and 
achieve bioluminescence, and move onto mutating the DNA. Luciferase doesn’t have 
many applications in today’s world because it remains so understudied. By mutating 
luciferase, we hope to shed some light on this protein and allow it to be widely used. One 
possible application is being explored by a company called the Glowing Plant Project, 
located in San Francisco. They are using the luciferase and inserting it into plant genomes 
to create glow in the dark plants. These have some amazing promise not just aesthetically 
in our gardens but also as a potential light source for third world and developing 
countries.  
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Introduction 
Bioluminescence is a term used to describe natural light emission from living organisms. 
These organisms include, but are not limited to the Firefly, Fungi, and Bacteria. All 
bioluminescent organisms exhibit a very similar chemical reaction to achieve light 
emission. This reaction involves a variety of molecules that are acted upon by a protein 
called luciferase. Luciferase oxidizes the molecules, and in the process releases a photon 
of light as seen in Figure 1. The exact function and chemical properties of luciferase are 
relatively unknown; this project aims to shed some light on the bioluminescent properties 
of luciferase.  
FMNH2 + O2 + RCHO → FMN + RCOOH + H2O + light 
 
 
Protein engineering is an extremely recent field of science. The importance of proteins 
was only realized in the last few decades. Since then, scientists have been trying to figure 
out ways to study proteins and how they work. One of the most successful methods used 
to study protein function is a technique called site directed mutagenesis. This technique 
takes advantage of the central dogma of biology. The central dogma of biology is a term 
used to describe the production of proteins from a specific DNA sequence. 
Fundamentally, a specific sequence of DNA corresponds to a specific sequence of amino 
acids. Every protein is therefore made up of a combination of20 known amino acids. The 
Equation 1. The chemical reaction of bacterial luciferase.   
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exact DNA sequences are used by the cell as a sort of “blueprint” to produce a sequence 
of amino acids, the building blocks of proteins, which give proteinstheir unique 
properties and function as can be seen in Figure 1. Any changes in the DNA sequence 
leads to an altered amino acid sequence, corresponding to a change in protein function. 
Novel techniques allow researchers to change single amino acids within a protein. Site-
directed mutagenesis involves changing single amino acids by altering the DNA and 
studying the resulting protein function. Using this method it is possible to map out which 
amino acids give rise to specific protein properties. Through lengthy experimentation, it 
is possible to check each and every amino acid of a protein and study the resulting protein 
function. This gives researchers a way to infer exactly which amino acids are critical to 
protein function. These critical amino acids are described as the “active site” of the 
protein and have the largest impact on the function of the protein. Unfortunately, the 
active site of luciferase is still unknown. Our project will use site directed mutagenesis to 
find mutants of luciferase with slightly altered functions. We will be using the bacterial 
luciferase responsible for the bioluminescence in deep-sea squids (Vibrio fischeri). Even 
though it is still under research, luciferase is already widely used in whole animal 
imaging, as a reporter gene, and as a monitor in bioreactors.  
 
 
 
 
 
Figure 1: The central dogma of Biology. DNA is transcribed into RNA, which is translated 
into amino acids. Amino acids are the building blocks of all proteins 
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Scientific 
A protein with a similar function to luciferase, Green Fluorescent Protein (GFP) has been 
extensively studied and is widely used in molecular biology, while luciferase remains 
comparatively unknown. GFP is used as a reporter gene, meaning it can be inserted into 
the DNA of an organism so that specific cells will express light under certain conditions. 
This is a very important tool as it can be used to tag certain genes or cells. For example, 
GFP can be inserted so that only those cells expressing a selective trait, such as diseased 
cells, will glow. Using this method, exact locations of diseases can be mapped within an 
organism. For GFP to express light, an ultraviolet light source must first shine on the 
cells. Following the excitation of the cell, the cells containing GFP will emit a greenish 
light. Bacterial luciferase has the advantage over GFP of not needing an excitation source 
to emit light. The luciferase gene already codes for the fatty acid substrates that act as 
fuel and are needed for light emission. The mechanism of GFP has already been 
comprehensively researched and mutant proteins discovered, such as Yellow Fluorescent 
Protein (YFP) and Blue Fluorescent Protein (BFP). This was accomplished by mutating 
the amino acids in the active site of the GFP, a result we hope to reproduce with 
luciferase. The Lux Operon is the specific gene that codes for bacterial luciferase and 
contains all the genetic material needed to produce functional luciferaseAs mentioned 
earlier, the active site of bacterial luciferase is still unidentified but it has been narrowed 
down to LuxA, which along with LuxB, are the genes necessary to produce the protein. 
Other parts of the lux operon include Lux E, G, C, and D, which code for the substrates 
or fuel needed for light emission. By researching and mutating LuxA we hope to find a 
modified version of luciferase that will express a different wavelength color, or brighter 
intensity.  
 
Aesthetic 
In addition to the scientific and medical applications of bioluminescence, there are further 
aesthetic purposes for luciferase. The Glowing Plant Project is attempting to take the lux 
operon and insert it into plant cells, creating plants that will glow in the dark.  If we are 
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successful in creating a luciferase protein that is brighter or a different color, we will send 
our results to the Glowing Plant Project, in hopes that they will be able to use our 
mutations of LuxA and insert them into their plants. Another exciting application of 
bioluminescence is as a potential light source. The biological mechanism of 
bioluminescence is 90% energy efficient, compared to 10% efficiency of standard 
incandescent bulbs, meaning almost no energy is wasted as heat. Conceptual ideas 
include using bioluminescence in street lighting, bio art, bio-light bulbs, and decorative 
purposes. While the light that luciferase produces is still too dim for many of these 
applications, we hope to make some of these ideas a possibility by discovering a brighter 
or different color mutant of luciferase. 
 
Literature Review 
Peat, Scott M., and Byron J. Adams. "Natural Selection on the LuxA Gene of 
Bioluminescent Bacteria." Symbiosis 46 (2008): 101-08. Brigham Young University. 
 
This source discusses an experiment in which 31 physiochemical properties were 
altered within the luxA gene. They tested for the presence or absence of these 
destabilizing selections within the protein structure. This paper is important as it 
shows the effect of certain mutations on the luxA gene causing destabilization. 
These are areas where our research should most likely avoid mutations.  
 
Tanner, John, Mitchell Miller, Keith Wilson, Shiao-Chun Tu, and Kurt Krause. 
"Structure of Bacterial Luciferaseβ2 Homodimer: Implications for Flavin 
Binding."Biochemistry 36.4 (1997): 665-72. Web. 
 
 This source is an important paper analyzing the function of bacterial luciferase. 
The paper explains the different effects of flavin binding in LuxB and expression 
levels. This paper helps to explain the binding of LuxB to LuxA including critical 
amino acid sites. These are sites that should not be mutated in the mutagenesis 
step.   
 
Swartzman, Elana, Shalini Kapoor, Angus Graham, and Edward Meighen. "A New 
Vibrio fischerilux Gene Precedes a Bidirectional Termination Site for the lux Operon." 
Journal of Bacteriology 172.12 (1990): 6797-802.  
 
This is an old source about the discovery of the luxG gene. Although it is outdated 
there is still a lot of good information about the lux operon in terms of secondary 
structure and gene sequencing.  
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Arnold, Frances Hamilton. and George Georgiou. Directed Evolution Library Creation: 
Methods and Protocols. Totowa, NJ: Humana, 2003.  
 
 
This book has a detailed protocol on how to use error prone PCR to create mutant 
libraries. This source is important because it provides a protocol and list of all the 
buffers and reagents needed for error prone PCR. Our group is most likely going 
to use site directed mutagenesis instead of error prone PCR, however this paper 
provides an alternative incase mutagenesis fails/  
 
Loefdahl, Per-Ake. On Bacterial Formats in Protein Library Technology. Stockholm: 
Universitetsservice US-AB, 2009.  
 
This source has a detailed description and list of all the current protein 
engineering methods used today. This source is important for our project due to 
its description of building protein libraries. 
 
 
Biotechnology Explorer. Ligation and Transformation Module: Instruction Manual. Bio-
Rad. 
 
This source is a protocol of how to ligate plasmids into bacterial cells. This will 
be important in our project as it will provide us a protocol along with what 
reagents and buffers we will need to obtain to perform the ligation.  
 
Engebrecht, Joanne, Kenneth Nealson, and Michael Silverman. "Bacterial 
Bioluminescence: Isolation and Genetic Analysis of Functions from Vibrio 
Fischeri." Cell 32.3 (1983): 773-81.  
 
 This source explains the original isolation of the lux operon from Vibrio fischeri. 
This is an old paper so the methods used are not up to date, however it still 
provides a background for the rest of our research. In addition, the same plasmid 
(pJE202) was used to host the lux operon, giving us information about how to 
specifically isolate the lux operon. 
 
Close D, Xu T, Smartt A, Rogers A, Crossley R, et al. (2012) The evolution of the 
bacterial luciferase gene cassette (lux) as a real-time bioreporter. Sensors (Basel) 12: 
732–752. 
 
 This source explains the use of luciferase as a real time bioreporter, one of the 
most important uses of luciferase in scientific research. This paper explains the 
methods used to isolate luxCDABE, the same genes we will isolate. The specific 
plasmids, promoters, and terminators used were explained to create an in vivo 
bioreporter gene. 
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Critical Analysis 
 
Most of the sources analyzed above are outdated and the techniques no longer used. 
While some of the sources provide information about the function of specific amino acids 
in the lux operon, the exact active site of bacterial luciferase is still unknown. We will 
have to use the known functions of specific amino acids in LuxA, such as the binding site 
to LuxB and structural amino sites in the protein, to narrow down which amino acids we 
will mutate. The function of these specific amino acids have been discovered as not 
responsible for light emission and instead are integral to the overall structure of the 
protein. These amino acids will be avoided in our mutagenesis step. In addition, many of 
the papers use an outdated technique to insert the DNA into E. coli. We will be using a 
more recent and advanced techniques called Overlap extension and Gibson Assembly. 
These steps will be explained in detail in the mutagenesis chapter. These new techniques 
will shorten and simplify the plasmid design step allowing us to move onto mutagenesis 
faster.  
 
Project Goals 
Our project aims to find a mutation of the protein luciferase through site directed 
mutagenesis that corresponds to a higher intensity or a different wavelength light 
emission. We will: 
 
1. Isolate necessary genes for bioluminescence from the host plasmid (pJE202)  
 
o Using a series reactions with specific primers we will cut out and isolate 
the specific genes of LuxB, LuxCD, and LuxEG from the host plasmid. 
 
2. Construct our DNA inserts using the isolated genes and insert into E. Coli to 
express luciferase.  
 
o The LuxA gene fragment will be ordered and paired with the previously 
isolated LuxB fragment. The LuxCD and LuxEG fragment will also be 
joined together in the correct orientation. The two gene fragments of 
  BIOE 
 
11 
 
LuxAB and LuxCDEG will be inserted into E. Coli cells. The E. Coli will 
then express luciferase and produce bioluminescence.  
 
3. Build a mutant plasmid library with mutations at every other amino acid in LuxA 
 
o Once we have E. Coli cells that successfully express luciferase we can 
begin the mutagenesis step. This step will introduce a single amino acid 
mutation to LuxA at a time.  
 
4. Screen cell cultures for desired mutations (intensity of bioluminescence and 
wavelength of bioluminescence) 
 
o Using a plate reader we will measure light intensity and wavelength of 
each amino acid change in the protein library. The data will be analyzed to 
search for E. Coli colonies that glow brighter or a different wavelength 
than the control original luciferase. 
 
5. Recombine successful mutants to search for further increased bioluminescence or 
change in wavelength.  
 
o The mutants that express luciferase at a different wavelength or greater 
intensity will be sent in for exact DNA sequencing.If we have multiple 
positive results, the resulting sequences can be recombined to test for 
further bioluminescent properties.  
 
We expect to successfully isolate the genes and engineer each of our plasmids so that 
luciferase expression can be measured in E. Coli cells. Following this step, we expect 
many cells will lose their luciferase expression when the mutations are introduced. 
Because proteins are incredibly complex and their interactions still not fully 
understood,changing random amino acids is expected to limit or inhibit luciferase 
expression. The lux operon has evolved so that luciferase functions at peak efficiency so 
it is highly likely that most mutations will destroy the function and perhaps even cause 
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cell death. We expect to find only one or two successful mutations out of the hundreds of 
mutations we will be performing.  
 
Backup Plan 
In a project of this size and complexity everything rarely goes as planned, so a backup 
plan is necessary. For every step of our project the methods we have chosen to utilizeuse 
are not the only option. As an example, if the gene isolation step does not work correctly, 
the plasmids can be constructed using restriction enzymes to cut the genes out instead of 
PCR primers.  The last goal in our project, recombination of successful mutants to find 
further mutations, is an optional step that could yield further results but is not necessary 
to successfully complete our project. This step is dependent on the success of the steps 
before it and so a backup for this step is not necessary. A complete list of project goals 
and potential backup plans can be seen in Table 1. 
 
Goal Plan Backup 
Isolate Genes PCR reaction with specific 
primers 
Use restriction enzymes to 
isolate gene fragments 
(LuxAB/LuxCDEG) 
Construct Plasmids Overlap extension and 
Gibson Assembly 
Use restriction enzymes for 
plasmid construction.  
Build Mutant Plasmid 
Library 
Site directed mutagenesis  Error prone PCR 
Screen for desired 
Mutations 
Plate reader to test for 
bioluminescence and 
wavelength 
Long exposure images of 
cultures followed by ImageJ 
analysis 
Recombine successful 
mutants 
Sequence and 
recombination of successful 
mutants. 
N/A 
 
 
 
Table 1: Overview of major project goals and methods for completion. A backup plan for each goal is 
also included in the right hand column. 
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Significance 
This project has the potential to be very important, as it could help to identify the active 
site of luciferase and widen its use as a reporter gene. It is possible that luciferase could 
replace GFP for some tasks.  GFP is currently so widely used because of its smaller size 
and ease of use, but luciferase has the advantage of not needing excitation to emit light. If 
a color variant of luciferase were found this would allow multiple assays to be run at the 
same time, something already possible with GFP/BFP/YFP.  
 
One of the main driving forces for this project is research for the Glowing Plant Project, 
which will introduce the luciferase gene into a plants genome so that it glows. Currently, 
the Glowing Plant Project has successfully produced plants that are bioluminescent but 
the intensity is still relatively low. By finding a mutant form of luciferase that will glow 
brighter, along with different colors of bioluminescence, the Glowing Plant Project will 
have a larger variety of products. If our project produces a mutant that is bright enough, 
these plants have the potential to act as eco friendly light sources. The seeds could be 
shipped to developing countries, and the plants could replace lamps in an eco friendly 
and cost efficient manner. Since bacterial luciferase requires no excitation, the plants 
would need no other maintenance other than keeping them alive. The potential to replace 
light sources that rely on electricity is very exciting especially since the light produced is 
heatless and nontoxic.  
 
Team Management 
Team management will not be an issue in this project. Since we are a group of two, 
coordination has not been an issue. We will be conducting our laboratory research at 
Santa Clara University. We both have very similar work ethics and nearly the same class 
schedule. This allows for seamless team coordination, which has been a success so far. 
The only work that will be performed alone is certain writing assignments. All of the lab 
work and project presentations will be conducted as a team with each member doing an 
equal part of the work.  
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Budget 
We will be receiving financial aid from two separate sponsors for our project. Both the  
Glowing Plant Project and Santa Clara University will provide funds for our research. 
The large majority of the costs for our project are the oligoprimers we will need to order 
to perform the mutagenesis step. The Glowing Plant Project has offered to fund this 
expensive step, while the funding received from Santa Clara University will cover any 
remaining costs. A detailed breakdown of the costs and funding can be seen in Table A-1. 
 
Timeline 
In Table A-2a proposed timeline for our progress can be seen. The first subsystem of our 
project, plasmid design, will be the most time consuming and complex process. Each 
DNA fragment must be correctly isolated and verified before they can be inserted into E. 
Coli. Once we have a baseline luciferase expression in our E. Coli cells the mutagenesis 
and screening step will be straightforward.  
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Plasmid Design 
 
A) Introduction-The first major subsystem is to design and create plasmids. A plasmid is 
a functional piece of circular DNA that can be inserted into cells.Once inserted into cells, 
the plasmid is translated (Translation is the process by which living cells read segments 
of RNA and translate it into the corresponding protein product) by the cell in order to 
produce proteins. There are 3 major components to a plasmid. The first is an origin of 
replication which is necessary for the replication and maintenance of the plasmid in host 
cells. The second is an encoded resistance. This resistance is important later on, as it is 
used to ensure cells have successfully absorbed the desired plasmid. The third and final 
component of a plasmid are the genes you want to study. Every gene has threenecessary 
components, a promoter to regulate gene expression, a ribosome binding site (RBS) to 
start gene expression, and finally a terminator to let the cell know when to stop 
transcription. An outline of the major components and where the come from can be seen 
below in Table 2. 
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B) Key Constraints - The two major decisions that were necessary to make in order to 
design the plasmids were what plasmids to use, and how to assemble our finalized 
plasmids. There are hundreds of different plasmids on the market, all containing various 
genes, origin of replications and resistances. Since we already knew what genes we were 
Component Why is it Important Source 
1) Origin of 
Replication 
Necessary for the replication and maintenance of the plasmid in the 
host cell. Tells the cell how many copies of the plasmid to make. 
Purified 
Plasmid 
2) Resistances Necessary to test for successful plasmid transfection. Plasmids 
encoding for a specific resistance will allow cells to grow in specific 
antibiotics. 
Purified 
Plasmid 
3) Desired Genes Required genes to carry out the experiment. The genes used in the 
experiment are LuxA/LuxB/LuxC/LuxD/LuxE/LuxG 
Artificial DNA 
-Promoter Small DNA segment at the start of desired gene, indicated how often 
a gene should be transcribed. Fine tuning weak or strong gene 
expression. 
Artificial DNA 
-Ribosome Binding 
Site (RBS) 
Small DNA segment at the start of desired gene where the ribosome 
binds, this is the site where the cell actually starts gene transcription. 
Artificial DNA 
-Terminator Small DNA segment at the end of desired gene, indicates to the cell 
when it should stop transcribing. Very last segment of a gene. 
Artificial DNA 
Table 2: Three major components of plasmid DNA. Origin of replication, resistances, and desired genes. Each desired 
gene in the plasmid must also contain three components, a promoter, an RBS, and a terminator. 
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working with, we wanted a plasmid containing no foreign genes. Resistances also weren’t 
a major issue as you they just serve as a test to see if the plasmid was successfully 
absorbed by the cells. The decision mostly came down to the origin of replication. We 
were looking for plasmids with a fairly high origin of replication, so that our specific 
genes would have high expression in our cells.  
The other major decision necessary to design our plasmids was how to assemble 
our final DNA fragments into one circular plasmid. The traditional way of linking two 
pieces of DNA is to use restriction enzyme sites. These sites need to be artificially 
designed into every DNA fragment so that they perfectly align and overlap. This requires 
a lot more planning and many more reagents. Our mentor however, advised us to use a 
brand new technique called Gibson Assembly, which allows for the joining of multiple 
DNA segments with no overlapping restriction sites. 
 
C) Detailed Description 
1. Essential Genes 
2. Choosing the Correct Plasmids 
3. Designing the Plasmids 
4. Isolating Lux Genes (PCR) 
5. Adding Terminators and Promoters (Overlap Extension) 
6. Putting the Plasmids Together (Gibson Assembly) 
 
1. Essential Genes - As discussed in the Introduction, the six genes necessary for 
light emission of luciferase are LuxA/B/C/D/E/G. LuxA/B code for the actual 
luciferase protein, which is what will be mutated in this experiment. In order to 
make mutating luciferase easier, LuxA and LuxB will be isolated on their own 
plasmid. Not having a very large and complex plasmid with all six of the lux 
genes on it will make the mutation process much simpler. The rest of the genes, 
LuxC/D/E/G,will be places in a separate plasmid of their own. 
 
2. Choosing the Correct Plasmids - Choosing the correct plasmids is essential, as 
the origin of replication for each plasmid determines how many copies of it are in 
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the cell. Since we are studying a light emitting protein, we want relatively high 
copy numbers for both plasmids, so that our product is expressed in high 
numbers. The one major concern when choosing plasmids was the ratio of our 
LuxAB plasmid to our LuxCDEG plasmid. Since we are mutating LuxAB, we 
need to ensure that it always has enough substrate or "fuel" for light emission. It 
would be a disaster if we successfully mutated LuxAB, but there wasn't enough 
substrate in the cell for luciferase to emit light. Realizing this, we needed to place 
LuxCDEG on a higher copy number plasmid than LuxAB. This ensures that there 
is always more of the substrate in the cell than the luciferase protein. This 
guarantees that any mutants produced will always have enough substrate and light 
emission. After talking it over with our advisor he recommended two plasmid, 
pBR322 and pACYC177. They are both very common plasmids and are widely 
available and well known. pBR322 has an origin of replication with copy number 
20. pACYC177 on the other hand has an origin of replication with copy number 
15. pACYC177 will contain the genes LuxA and luxB. pBR322 will therefore 
contain the genes LuxC, LuxD, LuxE, and LuxG as it has a higher copy number. 
 
3. Designing the Plasmids - After figuring out which plasmids should be used in 
our experiment, it was necessary to obtain an exact map of the plasmid. In order 
to successfully work with any piece of DNA, you need to know its exact base pair 
sequence (consisting of A,C,T,G). Out of the many programs to visualize DNA, 
we chose to work with Snapgene and ApE. Snapgene excels at giving users a 
visual overview of the plasmid and how it looks as a whole and can be seen in 
Figure 2 & 3. ApE on the other hand, specializes in DNA code, the exact 
sequence of A's, C's, T's, and G's. The two plasmids we decided to use are well 
known, so we had no problem finding and downloading the DNA files online. 
Our advisor then sent us the DNA files for our specific genes (LuxABCDEG). 
Now that we had the DNA files for our plasmids and our genes, it was possible to 
create our finalized plasmids within the computer program. This is an essential 
step in the process as it allowed us to visualize the exact genetic make-up of the 
plasmids we were creating.  
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Figure 2: Snapgene file of plasmid DNA pBR322 
Figure 3: Snapgene file of plasmid DNA pBR322 with the addition of LuxCDEG. 
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4. Isolating Lux Genes - In order to complete our finalized plasmids, it was 
necessary to isolate all of the required genes. Our mentor provided us with a 
plasmid (pJE202) which contained all of the Lux genes as well as some other 
genes which we didn't need. In order to clone the exact genes needed for our 
experiment we employed a technique known as polymerase chain reaction (PCR). 
This technique allows for the cloning and subsequent amplification of segments 
of DNA. By designing forward primers at the start of the gene and reverse 
primers at the end of gene, PCR is able to cut out and amplify a specific segment 
of DNA. This is demonstrated in Figure 4. The forward and reverse primers were 
visualized and designed in ApE. The designed primers are then sent to a company 
who synthesizes the exact primers. A detailed description of PCR and the 
protocols behind the reaction please visit (14).
 
 
 
 
 
 
 
 
Figure 4: Basic overview of polymerase chain reaction (PCR). Through a series of reactions, 
template DNA is reacted with forward and reverse primers. These primers effectively ‘sandwich’ 
the template DNA and amplify the sequence between them 
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5. Adding Terminators and Promoters (Overlap Extension) - Since we are taking 
our genes (LuxABCDEG) from a foreign plasmid, they do not all have the proper 
promoters and terminators. As discussed earlier, promoters and terminators are 
necessary in regulating gene transcription. Promoters tell a cell how often to 
transcribe the downstream genes while terminators tell the cell when the gene 
ends. Both are essential in successful gene expression and need to be included in 
both of our plasmids. Promoters are typically ~35 base pairs in length while 
terminators are typically ~100 base pairs in length. A list of promoters and 
terminators can be found at (13). We picked two of the most common promoters 
and terminators from this site, they are both very well-known and fully functional. 
Knowing the exact base pair sequence of our desired promoter and terminator 
allows for incorporation through overlap extension. This process is very similar to 
the gene isolation technique described above. Similarly to gene isolation, the 
DNA undergoes PCR with forward and reverse primers. The only difference is 
that the forward and reverse primers don’t start and end on a specific gene. 
Instead, the forward and reverse primers are complements of each other, and will 
therefore bind to each other. By ordering primers that have the exact sequence of 
the desired promoter and terminator, it is possible to incorporate these new 
sequences to the original DNA. The process is easier to comprehend visually as 
can be seen in Figure 5. 
 
 
 
 
 
 
Figure 5: Overlap Extension. Part A represents the synthetic promoter to be added to the gene 
while part B represents the gene itself. Both parts share a small region of overlap which allow them 
to bind to each other during PCR. 
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6. Putting the Plasmids Together (Gibson Assembly) - The final step of plasmid 
design is to assemble all of the acquired DNA sub-units into one final plasmid. 
Up to this point we have acquired our genes, acquired our plasmids, isolated the 
required genes and incorporated promoters and terminators where necessary. This 
results in many small fragments of DNA which need to be assembled into one 
final product. The traditional method of joining multiple segments of DNA is by 
designing all of the products to contain matching restriction sites. These 
restriction sites are chewed back by restriction enzymes and then joined together. 
This requires a lot more planning introduces many unnecessary external variables. 
In 2009, Dr. Daniel Gibson invented a technique called Gibson Assembly to join 
multiple DNA fragments in one single reaction without the need for restriction 
enzymes. By designing the DNA inserts to have 15-20 base pairs of overlap, 
Gibson assembly can join up to six DNA fragments into one final plasmid product 
as can be seen in Figure 6. An in-depth analysis and procedures for Gibson 
Assembly can be found on NEB’s website (7) 
 
 
 
 
 
Figure 6: Gibson Assembly. By designing fragments of DNA to share overlapping regions (A&B), 
they are able to be chewed back by T5 Exonuclease to create overhang regions. These 
complementary overhang regions are then able to bind to each other to form one final product. 
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D) Supporting Analysis and Expected Results - One of the ways to verify our progress 
is through the use of gel electrophoresis. After isolating the required genes, it is 
possible to run the genes on a gel. This process establishes the presence and length of 
a gene product after gene isolation. The basic principle behind this technique is that 
and electrical current pulls DNA products through a gel. Smaller products are able to 
travel further through the gel as they don’t interfere with gel as much as larger 
products. By comparing DNA products to a constant base pair ladder, it is possible to 
determine the presence and length of genes, as can be seen in Figure 7.  
 
 
 
 
 
 
 
After running all of the isolated genes on a gel, and determining that they are all present 
at their correct lengths, the plasmids are assembled through Gibson Assembly.  This is 
the step that brings every other step together. In order to test if our plasmid products are 
Figure 7: Gel picture of isolated LuxEG genes. The constant base pair ladder can be seen at the 
bottom. LuxEG genes are the four vertical bright bands. 
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fully functional we have to insert them into host E.coli cells. The first test will be to 
analyze bioluminescence. If the cells are glowing we know that we have successfully 
incorporated all of our genes and can move on to the mutagenesis step. If the cells are not 
glowing, it becomes a lengthy troubleshooting process. Since we have two plasmids, the 
problem could lie in one of the plasmids or even both of them. To test if the individual 
plasmids are functioning we have to test them against their resistances. As discussed 
earlier, every plasmid has an inherent resistance coded onto it. Our pACYC177 plasmid 
codes for resistance to the antibiotic Kanamycin, while our other plasmid pBR322 codes 
for the resistance to the antibiotic Ampicillin. By inserting our plasmids into E.coli host 
cells and growing them in media laced with Ampicillin and Kanamycin, it possible to see 
which plasmid is functional and which is not. If our cells grow in media+Ampicillin, we 
know that our pBR322 plasmid is fully functional. If our cells grow in 
media+Kanamycin, we know that our pACYC177 plasmid is fully functional. If they are 
unable to grow in any of these media, we know that the cells are not resistant to any of 
the antibiotics and both of our plasmids are not functional.  
 
E) Backup Plan - The one step in plasmid design that has a clear backup plan is the final 
plasmid assembly. As discussed earlier, the traditional method of joining multiple 
segments of DNA is through restriction sites. If we hit a brick wall in our attempt to join 
our DNA through Gibson Assembly, we can fall back to joining them through restriction 
sites. For all of our other experimental steps, including Gibson Assembly, we will need to 
trouble shoot the experiment by repeating it many times, changing a single parameter 
each time. The best way to troubleshoot experiments is to seek advice from people who 
have had success with the experiment. Since many of our professor’s and senior design 
advisor have been able to successfully complete most of the experiments outlined in the 
plasmid design section, we will look to them for help in tweaking our experiments until 
they yield positive results. 
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Mutagenesis 
 
A) Introduction - The basis of all genetic engineering stems from the central dogma of 
biology. This idea is that DNA codes for amino acids which are the building blocks of 
proteins. By changing the DNA sequence, you change the amino acid sequence, which 
changes the final protein product. Ultimately we are trying to mutate luciferase which is a 
protein. Attempting to isolate a protein and manually change its sequence without the 
help of cellular machinery is extremely complex. The easiest method of mutating proteins 
is to start at the DNA level and then having living cells translate the mutated protein for 
you. This is the method we will be utilizing for our protein mutagenesis process.  
 
B) Key Constraints - When it comes to mutating DNA there are dozens of techniques. 
Three of the most prevalent techniques utilized in today's industry are error-prone PCR, 
combinatorial mutagenesis, and site-directed mutagenesis. Error-prone PCR, or ePCR for 
short, is a random mutagenesis method that utilizes PCR, the experimental method 
discussed earlier. The DNA involved is the same as regular PCR, you need your template 
DNA (DNA you want to mutate) and forward and reverse primers that flank your 
template DNA on both ends. The only difference is that during ePCR, the reaction 
conditions are changed. This can be accomplished by using less efficient polymerases or 
adding Mn
2+
 ions to the solution. By offsetting the ideal PCR conditions the DNA 
translation is disrupted and random mutations occur. This technique is very random and 
can mutate the same spot over and over. There is no real control on where and how many 
mutations are made. Sometimes dozens of mutations are made in one reaction which will 
almost always disrupt protein function. 
One of the most popular and effective techniques to DNA mutation is combinatorial 
mutagenesis. This technique however requires two proteins for mutagenesis. The proteins 
need to be fairly similar to each other as well. The proteins are essentially spliced and 
mixed and put back together. The final product is a mixture of proteins which are 
combinations of the two parent proteins. This technique offers a quick and easy way to 
produce a library of mutant proteins. This technique is not appropriate for our project 
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because it doesn't reveal anything about the parent protein. Since we are trying to study 
one specific type of luciferase, it doesn't make sense to create an alternate protein that is 
only half of the original luciferase. In order to actually reveal the secrets and potential 
active site of luciferase, it is important we maintain our mutant proteins as close to the 
original as possible.  
 
C) Detailed Description - The technique we have chosen to mutate our protein is called 
site-directed mutagenesis. This technique allows for the mutation of single sites within 
the protein and is very controlled and methodical. Once again, this technique uses the 
basic principles of PCR. You need template DNA and forward and primers. Primers 
typically exactly match the sequence of the template you want them to bind to. During 
site-directed mutagenesis you purposefully incorporate single changes in the primers. 
These single changes are located in the center of the primers, and are flanked by 10-15 
base pairs of correct sequence on both sides. These single point mutations don't disrupt 
proper primer binding as they still match the original DNA sequence everywhere else as 
can be seen in Figure 8. This technique allows for the mutation of specific sites. The rest 
of the DNA stays exactly the same except for one single change which is introduced. This 
allows for methodical mutation as you can mutate each and every point of the protein and 
study the effect of that one mutation.  
 
The drawback of this technique is that it is very time and money consuming. Every single 
mutations site needs to have its own primers and be run in its own test tube. In order to 
analyze the entire luciferase protein would cost over $5,000 and would take weeks of 
rigorous lab work to complete. Research of literature has given us some clues as to what 
sites to begin mutating. The very end of LuxA, where it binds to LuxB has been 
determined to not have a significant contribution to its bioluminescence. We will 
therefore steer clear of this region. There are also a few other small regions of the protein 
that are thought to be responsible for protein structure and not protein function. Because 
nobody knows exactly what part of the protein is responsible for light emission, it is a 
guessing game for which sites to mutate. We will mutate the sites we believe are most 
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likely to yield successful mutations until we run out of money or time, whichever comes 
first.  
 
 
 
 
 
 
D) Supporting Analyses and Expected Results - In order to determine if we have 
successfully mutated our DNA and therefore proteins, we will need to analyze them in a 
screening process which is the last and final step of our project. The details of this step 
are covered in the screening chapter. The basic idea is that after mutating our DNA we 
will insert the plasmids into E.coli cells and have them produce our mutant proteins. We 
will analyze the E.coli for changes in bioluminescent properties. If screening doesn't 
yield any successful mutants we will go back to mutation and create more mutants to 
analyze. This step is closely intertwined with screening, as it becomes a constant cycle of 
creating mutants, and then analyzing them. 
If we really hit a brick wall and aren't finding any mutant proteins we can get our DNA 
sequenced. After performing mutagenesis, we can send our product out to a company 
who can analyze it and tell us the exact base pair (A,C,T,G) sequence of our sample. That 
way we can figure out if we were able to successfully mutate the DNA and the proteins 
just aren't functional, or if our mutagenesis step went awry.  
 
Figure 8: Site-directed mutagenesis. Original DNA is shown on the bottom strand. The 
primer is located on the top. The primer perfectly matches original DNA except for one 
mutation site located at the center. 
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E) Backup Plan - As discussed earlier, there are many forms of mutating DNA. If we are 
having trouble with site-directed mutagenesis, we can switch to error-prone PCR or even 
recombine our protein with another protein through combinatorial mutagenesis. As with 
every other part of this project, the experimental procedures are very sensitive and will 
require a lot of work and tweaking to get just right.  
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Screening 
 
A) Introduction - The screening subsystem of our project is the final step and will be 
used to quantitatively and qualitatively measure the success of our mutations. This is the 
most straightforward of the three steps, and will have two distinct parts: a quantitative 
and qualitative step. We will be testing the mutant colonies from the mutagenesis step for 
any form of bioluminescence. The quantitative step will be performed by our group and 
involves hand-picking colonies that show any bioluminescence. Any cells that express 
light will be picked and harvested. After picking, the glowing cells will be placed in a 
plate reader which will quantitatively measure the wavelength and light intensity from 
each cell colony. We will have a benchmark value for bioluminescence from our original 
un-mutated cells of both wavelength and intensity. By comparing the wavelength and 
light intensity of our mutants to the benchmark values, we will be able to ascertain if our 
mutations were successful.  
 
B) Key Constraints - The light emitted from the bioluminescent cells is very low 
intensity so our group must be careful and precise to obtain our quantitative data. The 
device we use will have to be very sensitive in order to pick up differences in light 
intensity and wavelength, given that the benchmark data will be very low intensity. We 
will be using the Tecan Infinite 200 Pro plate reader on the glow luminescence setting to 
obtain our data. Because the light that is emitted from the cells is very weak and we have 
hundreds of colonies to screen we decided to use the plate reader over taking long 
exposure images and doing image analysis. This will greatly speed up the screening step 
and will save our group many hours of image analysis. In addition, by keeping the 
quantitative screening step consistent we will be able to compare our data of wavelength 
and intensity across all of our cell colonies.  
 
C) Design Description - It will be important to have a clear benchmark for intensity and 
wavelength to compare the rest of our data to. This step will be done once we have 
completed the plasmid design and have successfully introduced our plasmids into the E. 
Coli cells. To keep our data consistent we will use the plate reader to obtain an average 
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wavelength and light intensity for a given cell colony. The cells measured for the 
benchmark will have to be counted using a hemocytometer so we can obtain a value that 
is proportional to the cell number. Because each well in the plate reader will not have the 
same number of cells the intensity will differ from well to well. Therefore, it is important 
that we compare our light intensity values to the number of cells in each well. Finally we 
will obtain a value of lumens per cell, which we will then use to compare the positive 
results from the mutagenesis step.  
 
Following the mutagenesis step, cells will be grown for 12-14 hours in 96 well plates. In 
a dark room, the plates will be hand screened for colonies that exhibit bioluminescence. 
Any wells that contain glowing cell colonies will be successful mutants. These colonies 
will be labeled, counted, and then screened using the plate reader to obtain values of 
wavelength and light intensity per cell. These values can be compared to the benchmark 
values to gauge if the mutant cells have a greater intensity or any significant change in 
wavelength.  
 
 
D) Expected Results - The bacterial luciferase protein has evolved to perform at peak 
efficiency so it is expected that the great majority of mutations will disrupt the overall 
function of the protein rather than alter it. Therefore, we expect that the majority of our 
mutations will completely stop bioluminescence or weaken it significantly. However, out 
of the 300 mutations we anticipate that one or two will produce either a significant 
change in wavelength of greater than 100nm shift or a greater intensity. The peak 
wavelength for bacterial luciferase is recorded around 490nm,a bluish-green light, and we 
expect our benchmark results to be within 15nm. Following this data, we will compare all 
positively screened mutants from the qualitative step in terms of wavelength and 
intensity. Finally, mutants that have passed the qualitative step will be sent in for 
sequencing. We expect only one or two colonies of the hundreds of mutations will be 
successful. 
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E) Backup Plan - In case the plate reader malfunctions or is not sensitive enough to 
measure small differences in wavelength or intensity, we will have access to a high 
quality camera and tripod. We can use this setup to take long exposure images of our cell 
plates and measure intensity and wavelength using image analysis. The program ImageJ 
can be used to perform image analysis on these images. The process would be much more 
time consuming and would greatly slow down the progress of our project. Each 96 well 
plate would have to be analyzed for intensity and each of the 96 wells done individually.  
 
 
 
Materials and Methods 
 
DNA 
Lux Operon-The Lux Operon DNA was obtained in plasmid form (pJE202) from 
Biocurious. 
 
PCR Primers-- All primers used in the PCR were custom ordered from Elim Biopharm. 
The primers were resuspended in 75µL ddH20 and concentration measured (ng/µL) via 
nanodropper(Thermo Scientific Nanodrop 2000). These primers were diluted to 15-
50ng/µL and later used in PCR.  
 
Plasmids-- pACYC177 and pBR322 were ordered from New England Biolabs. The 
pACYC177 plasmid was obtained in an E. coli strain (ER2420). A plasmid DNA 
extraction procedure was run to isolate the pACYC177 plasmid.  
 
Protocols 
 
Transformation into E. coli Cells (Plasmid Amplification) 
1. Thaw E. coli cells on ice for 5-10 minutes 
2. Transfer 2µLof plasmid DNA into the 50 µL aliquot of E. coli cells. Incubate 
transformation reaction on ice for 30 minutes. 
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3. Heat shock the transformation for 30 seconds at 42°Cand then place 
transformation on ice for 2 minutes. 
4. Add 500 µL LB Media and incubate the transformation at 37°C for 60 minutes 
with shaking at 225 RPM. 
5. Plate 50 µL of the incubated solution onto (+)Ampicillin resistant LB-agar plate. 
Incubate overnight for 12-16 hours at 37°C.  
6. Pick 4 different colonies from plate and insert into 5mL LB/5µL Ampicillin 
solution.  Culture overnight for 14-15 hours at 37°C. 
 
 
 
Extraction of Plasmid DNA from E. coli Cells (Qiagen Mini Plus Plasmid DNA 
Extraction System) 
 
1. Pellet 1-5mL bacterial overnight cultures by centrifuging at >8000 rpm for 3 min 
at room temperature.  
2. Resuspend pelleted bacterial cells in 250µL Buffer P1 and transfer to a 
microcentrifuge tube. 
3. Add 250µL buffer P2 and mix thoroughly by inverting the tube 4-6 times until the 
solution becomes clear. Do not allow the lysis reation to proceed for more than 5 
min. If using LyseBlue reagent the solution will turn blue.  
4. Add 350µL Buffer N3 and mix immediately and thoroughly by inverting the tube 
4-6 times. If using Lyse Blue, the solution will turn colorless.  
5. Centrifuge for 10 min at 13,000rpm in a table-top centrifuge.  
6. Apply the supernatant from step 5 to the QIAprep spin column by decanting for 
pipetting. Centrifuge at 9000rpm for 30-60 sec and discard the flow-through. 
7. Wash the QIAprep spin column by adding 750µL buffer PE. Centrifuge at 
9000rpm for 30-60s and discard the flow-through. 
8. Centrifuge at 13,000rpm for 1 min to remove residual wash buffer.  
9. Place the QIAprep column in a clean 1.5 mL microcentrifuge tube. To elute the 
DNA, add 50µL ddH20 to the center of the QIAprep spin column. Let stand for 1 
min, then centrifuge at 13,000rpm for 1 min.  
10. Use nanodropper to drop 1µL of  and determine concentration in ng/µL. 
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Polymerase Chain Reaction (PCR) Procedure (Eppendorf Mastercycler Gradient 
Machine): 
 
1. The following reaction is set up in a micro centrifuge tube.  
 
                                            
Reaction Amount 
Template DNA 50ng 
Forward-Primer (Elim Biopharm)            100ng 
Reverse-Primer (Elim Biopharm)             100ng 
Taq Polymerase (Promega) 1µL 
dNTP’s 2µL 
10x Buffer (New England Biolabs) 10µL 
ddH20 X µL 
Total: 100µL 
 
 
2. 100µL PCR reaction mix was split into two 50µL reaction tubes and placed into 
Thermocycler (Eppendorf Mastercycler) 
 
 Program: 
 
 1. T=98.0°C    0:00:30 
 2. T=98.0°C    0:00:10 
 3. T=58.0°C    0:00:35 
 4. T=72.0°C    0:02:10* 
 5. GoTo 2     REP 29 
 6.T=72.0°C    0:10:00 
 7. HOLD  4.0°C 
 *The time for step 4 was determined by the length of DNA fragment being 
 extracted (1000bp/min). For example 0:02:10 = 2100bp. 
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Gel Electrophoresis Procedure 
 
We used a 0.8% agarose gel mixture for all gel experiments.  
 
1. Add 0.4g of agarose to 50mL1X TAE Buffer in Erlenmeyer flask for 0.8% 
agarose gel mixture.  
2. Microwave for 30 seconds or until mixture was boiling.  
3. Let mixture cool and add 2.5µL of Ethidium Bromide to agarose gel mixture.  
4. Add 10µL of the loading dye (Invitrogen DNA Stain) to each 50µL PCR sample. 
5. Pour gel in mold and let mixture cool until it hardens.  
6. Add 30µL of PCR reaction into each well along with 7µL of 1Kb ladder (Alfa 
Aesar DNA Marker High Range 1Kb-10Kb) 
7. Run gel at a constant voltage of 120V for 30min at 400mA.  
8. View gel with UV light source and take screenshot.  
 
Gel Extraction (Qiagen) 
 
1. Cut out gel fragment containing DNA bands. 
2. Weigh the gel fragment. Add 3 volumes of QG buffer to 1 volume gel. (1g=1mL) 
3. Incubate at 50°C for 10 min. Vortex every 2-3 min to help gel dissolve. 
4. Add 1 Volume isopropanol (1g=1mL) 
5. Place in spin column and centrifuge for 1 min at 9,000 rpm. Discard flowthrough 
and place column in the same tube. If reaction is >800µL, keep adding and 
centrifuging until it has all be spun through. 
6. Add 750µL PE Buffer to column and centrifuge at 9,000rpm for 1 min. Discard 
flowthrough. 
7. Centrifuge at 9,000rpm in 2mL collection tube for 1 min to remove residual wash 
buffer.  
8. Place in clean 1.5mL centrifuge tube. 
9. To elute DNA, add 30µL ddH20 to center of column and centrifuge for 1 min.  
 
 
Gibson Assembly (New England Biolabs) 
 
1. Set up on Ice: 
 
Reaction Volume Amount 
PCR Fragments+ Linearized Vector (XµL)(0.02-0.5pmols*) 
Gibson Assembly Master Mix (10µL) 
ddH20 (10-XµL) 
Total Volume: 20µL 
*pmols=(weight in ng) x 1,000/(basepairs x 650 daltons) 
 
2. Incubate mix at 50°C for 60min.  
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Results 
 
 
Our project is difficult to show results for, as each step in the project can’t be physically 
seen. There are two main methods we used to obtain results and make sure that our steps 
were working. Gel electrophoresis allowed us to verify and confirm that our PCR steps 
worked correctly. These were integral in making sure that the DNA segments that we cut 
out were the correct size and the DNA that we wanted. The second method was 
transfecting E. coli cells a plasmid containing a certain antibiotic resistance encoded into 
it. If E. coli containing our plasmids were able to grow on the antibiotic LB plate, then 
the plasmid must be fully functional.  
 
The first step in our project was to amplify the pJE202 plasmid obtained from 
Biocurious. After following the transformation and plasmid extraction protocols, we 
achieved a final DNA concentration of 26.2ng/µLfor our pJE202 plasmid. Following this 
step we designed primers to cut out each of our DNA fragment subsections, LuxAB, 
LuxCD, and LuxEG. The pJE202 plasmid served as the template DNA for each of the 
PCR reactions. The results from our PCR DNA extraction step can be seen in the gel 
images shown in Figures 9-11. As seen in Figure 10a, PCR can produce errors for a 
variety of reasons. The experiment was repeated with the same primers, PCR conditions, 
and template DNA. Figure 10b shows that the LuxCD fragment was successfully 
obtained and verified.  
 
Following the isolation and verification of each of our DNA fragments the next step was 
to prepare each piece for Gibson Assembly. The new plasmids (pACYC177, pBR322) 
were linearized using custom ordered PCR primers that cut open the plasmid in certain 
sections. The linearized plasmids were gel verified and stored until each fragment was 
ready. LuxCD, LuxEG, and Lux AB also had to be prepared for Gibson Assembly. The 
15-20bp overlap between each fragments in critical to Gibson Assembly, so these 
sections had to be added to each of the fragments. This was done using a method called 
overlap extension. Overlap extension is a PCR with specific primers that elongate the 
template DNA. We performed overlap extension on each of our 3 DNA fragments, but 
  BIOE 
 
36 
 
since the fragment is only being elongated by 15-20bp, these were not able to be gel 
verified. The difference between a DNA fragment that is 2000bp and 2015bp would be 
indistinguishable on a gel. Instead, we assumed that the PCR worked correctly for each of 
these fragments and moved on to the next step: Gibson Assembly. We ran the Gibson 
Assembly protocol for each of our plasmids and DNA fragments (LuxAB-pACYC177, 
LuxCD/LuxEG-pBR322) and then transformed them into E. coli cells and grew them on 
seperate antibiotic LB plates. The cells containing pACYC177 was grown on a 
Kanamycin (+Kan) plate, because pACYC177 contains the Kanamycin resistance. The 
cells containing pBR322 were grown on an Ampicillin (+Amp) plate, because pBR322 
contains Ampicillin resistance. The results can be seen in Figure 12. The cells containing 
the pACYC177 plasmid did not grow, while growth can be seen in the pBR322 
containing E. coli. 
 
 
 
  
 
 
 
 
Figure 9. Gel of LuxAB DNA fragments. The 4 bright bands correspond to the DNA 
obtained from the PCR. The 4 bands are directly above the 2,000 bp ladder. 
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Figure 10. A) Gel of LuxCD DNA fragments. Only 2 out of 4 bands can be seen, indicating a problem 
with the PCR. The bands are also slightly offset corresponding to different sizes of DNA fragments. 
B) Gel of LuxCD DNA fragments. All 4 bands can be seen in this gel corresponding to a successful 
PCR and gene extraction.  
 
A B 
  BIOE 
 
38 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Gel of LuxEG DNA fragments. The 4 bright bands are directly beneath the 
2,000bp ladder as expected. The image is colorized because it was taken with a different 
camera. 
 
Figure 12. Plates showing the growth of e. Coli after plasmid has been 
transfected into the cells. pACYC177 was grown on a +Kan plate and pBR322 
on a +Amp plate. 
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Discussion 
 
The results obtained over the course of this project were all expected. It took a few weeks 
of troubleshooting to get all of the experiments up and running, but once we were 
familiar with the experimental procedures, the results obtained were all expected. The 
DNA fragments we were able to isolate through PCR extraction were all the expected 
lengths. By running the gels we are able to confirm that our PCR reactions were able to 
successfully isolate the correct length and therefore sequence of DNA. The successful 
creation of our pBR322 plasmid proves without a doubt that we were successful in 
isolating and creating overlap between our Lux CD, Lux EG, and linearized pBR322 
fragments. The other plasmid, pACYC177 did not yield a functional plasmid, some 
possible reasons for this are discussed below. 
 
The successful creation of one our plasmids but not the other provides very essential 
feedback. This proves that we were able to successfully set up and carry out Gibson 
Assembly in order to join our DNA fragments into one finalized plasmid. This provides 
valuable insight as we can be confident that our overall experimental system is 
functional, and only certain parameters that differ between the two experiments need to 
be tampered with. One of the biggest concerns we had as to why our pBR322 plasmid 
came out functional and our pACYC177 plasmid did not is that our DNA concentrations 
for pACYC177 were substantially lower. The Lux AB fragment used in our Gibson 
reaction was at a substantially lower concentration that the rest of our DNA. This 
required that we dilute the rest of our DNA in order to achieve equal concentration of 
DNA for the Gibson reaction. This mass dilution of our DNA and small final 
concentrations of product could have led to our experiment going awry.  
 
Another possible suggestion is that some of our overlap extension reactions did not run to 
completion. There is no way for us to check if we have successfully completed overlap 
extension on our budget. The small 30 base pair overlap regions introduced by overlap 
extension are not long enough to be visualized by gel electrophoresis like our other 
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~2000 base pair fragments. If overlap extension wasn't successful on any of the DNA 
fragments, then the whole Gibson reaction would not yield any results.  
 
In order to try to run a successful Gibson reaction for our pACYC177 plasmid, we have 
to essentially re-isolate the DNA and run overlap extension over. This isn't too much of 
an issue as we still have all of the reagents from the first round of experiments and have 
all of the experimental procedures down to an art. This will allow us to achieve higher 
concentrations of our Lux AB fragment as well as redo our overlap extension. By redoing 
the experiments for our pACYC177 plasmid leading up to Gibson we can both obtain 
higher concentrations of our Lux AB fragment as well as redo our overlap extension. 
These two parameter should allow the successful creation of our pBR322 plasmid. With 
this plasmid made, we can insert both of the plasmids into cells and start the mutagenesis 
portion of our project.  
 
Conclusion 
The overall goal of this project was to setup a genetic system for the expression of a 
bioluminescent protein luciferase, and then mutate this system in order to enhance 
bioluminescent properties. To set up this bioluminescent system, we first needed to 
isolate all of the genes necessary for bioluminescence. These six genes came in pairs of 
two, LuxAB, LuxEG, and Lux CD. Once the genes were isolated it was necessary to put 
them back together into two final plasmids. These plasmids required custom promoters 
and terminators which we constructed from synthesized primers. Once the two plasmid 
system is in place we can begin to mutate and screen for desirable mutant proteins. We 
have successfully isolated all of the DNA necessary to make both of our plasmids, and 
successfully synthesized our pBR322 plasmid. 
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Project Objective Complete 
In 
Progress 
Future 
Work 
DNA Isolation       
Lux CD       
Lux EG       
Lux AB       
Linearized pACYC177       
Linearized pBR322       
        
Promoter/Terminator Construction       
pBR322 Promoter       
pACYC177 Promoter       
pACYC177 Terminator       
        
Gibson Assembly       
Complete pBR322 Plasmid       
Complete pACYC177 Plasmid       
        
Mutagenesis       
        
Screening       
 
 
 
The most time consuming and difficult portion of this project was to create a plasmid 
from scratch. Mutating a protein is fairly simple, and is a matter of money and time. The 
real challenge in this project was to isolate specific genes and then put them back 
together so a cell could read the DNA and produce proteins. We were able to isolate all of 
the DNA fragments necessary for bioluminescence and verify them through gel 
electrophoresis. These isolated DNA fragments then had to put back together into one 
final plasmid. This requires that each fragment contains overlap with the other fragments, 
Table 3. Completion and progress of milestone steps. 
  BIOE 
 
42 
 
which is very hard to verify. By successfully creating one of our plasmids we are able to 
prove that we were able to introduce the correct overlap between the fragments and 
successfully carry out the Gibson Assembly reaction. The other plasmid was not 
successful, and we are working to get the experiment just right for this plasmid. The 
important thing is that we were able to successfully create one plasmid, so the other 
should just require small experimental tweaks. Once we have been able to successfully 
create our other plasmid we will have obtained bioluminescence and can start mutating 
the DNA. 
 
Once we have both of our finalized plasmids, we can begin to mutate Lux A and look for 
mutant proteins. This mutation process involves the same experimental techniques as our 
gene extraction. The mutation is a matter of time and money and likely won't pose any 
experimental hardships. Once we have mutated our Lux A DNA we will insert it into 
E.Coli cells and have them express our mutated proteins for us. We will then screen these 
mutated proteins to look for any desirable bioluminescent properties.  
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Appendix 
A-1 Budget 
 
Item Cost Paid By 
Required  
 
 
 
Oligos Plates (Primers) $500-2000 Glowing Plant Project 
pBR322 Plasmid $100 SCU Aid 
pACYC Plasmid $0 SCU Aid 
PCR Primers 
 
$200-300 
 
SCU Aid 
 
Codon Optimized LuxA $300 SCU Aid 
Qiagen Mini-Prep Kit $80  
SCU Aid 
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